Glycemic Control With Insulin Glargine Plus Insulin Glulisine Versus Premixed Insulin Analogues in Real-World Practices: A Cost-Effectiveness Study With a Randomized Pragmatic Trial Design-Reference-Cited by-同舟云学术

Glycemic Control With Insulin Glargine Plus Insulin Glulisine Versus Premixed Insulin Analogues in Real-World Practices: A Cost-Effectiveness Study With a Randomized Pragmatic Trial Design

Published:2011-07 Issue:7 Volume:33 Page:841-850
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Levin Philip A.,Zhang Quanwu,Mersey James H.,Lee Francis Y.,Bromberger Lee A.,Bhushan Madhu,Bhushan Rajat

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference42 articles.

1. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes;Janka;Diabetes Care,2005

2. Economic evaluation of the treatment of type 2 diabetes with insulin glargine based on the LAPTOP trial;Janka;Eur J Health Econ,2008

3. Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs;Raskin;Diabetes Care,2005

4. Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US;Ray;Diabetes Obes Metab,2007

5. Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes;Qayyum;Ann Intern Med,2008

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges;World Journal of Diabetes;2024-05-15

2. Glycemic control and adverse effects in patients with type 2 diabetes receiving basal-bolus insulin regimen versus premixed insulin regimen: An observational study;Indian Journal of Medical Sciences;2023-12-15

4. Twenty Years of Insulin Gla-100: A Systematic Evaluation of Its Efficacy and Safety in Type 2 Diabetes Mellitus;Diabetes Therapy;2022-06-30

5. The Case for Using Human Insulin;The American Journal of Medicine;2020-02